Combined operations in conjunction with intracavitary chemotherapy for treatment of patients with peritoneal mesothelioma. Immediate results. Experience of the Thoracic Department of the N.N. Blokhin Russian Cancer Research Center of RAMS

A. G Abdullaev; B. E Polotskiy; M. I Davydov

doi:10.17816/onco40028

Russian Journal of Oncology ›› 2014, Vol. 19 ›› Issue (2) : 12 -15. DOI: 10.17816/onco40028

Articles

research-article

Combined operations in conjunction with intracavitary chemotherapy for treatment of patients with peritoneal mesothelioma. Immediate results. Experience of the Thoracic Department of the N.N. Blokhin Russian Cancer Research Center of RAMS

Author information +

History +

PDF

Abstract

The paper presents a detailed analysis of the immediate results of the treatment of patients with peritoneal mesothelioma who underwent cytoreductive surgery combined with intracavitary hyperthermia chemoperfusion in the thoracic department of the N.N. Blokhin Russian Cancer Research Center in the period from 2008 to 2013.

Keywords

mesothelioma of the peritoneum / intracavitary hyperthermic chemoperfusion / cytoreductive surgery

Cite this article

Download citation ▾

A. G Abdullaev, B. E Polotskiy, M. I Davydov. Combined operations in conjunction with intracavitary chemotherapy for treatment of patients with peritoneal mesothelioma. Immediate results. Experience of the Thoracic Department of the N.N. Blokhin Russian Cancer Research Center of RAMS. Russian Journal of Oncology, 2014, 19(2): 12-15 DOI:10.17816/onco40028

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Tan G.H., Cheung M., Chanyaputhipong J., Soo K.C., Teo M.C. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritonealmesothelioma. Ann. Acad. Med. Singapore. 2013; 42 (6): 291-6.

[2]	Turner K., Varghese S., Alexander H.R. Current concepts in the evaluation and treatment of patients with diffuse malignant peritoneal mesothelioma. J. Natl. Compr. Cancer Netw. 2012; 10 (1): 49-57.

[3]	Deraco M., Nonaka D., Baratti D. et al. Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion. Ann. Surg. Oncol. 2006; 13 (2): 229-37.

[4]	Glehen O., Mohamed F., Sugarbaker P.H. Incomplete cytoreduction in 174 patients with peritoneal carcinomatosis from appendiceal malignancy. Ann. Surg. 2004; 240 (2): 278-85.

[5]	Canda A.E., Sokmen S., Terzi C. et al. Complications and toxicities after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann. Surg. Oncol. 2013; 20 (4):1082-7. doi: 10.1245/s10434-012-2853-x. Epub 2013 Mar 2.

[6]	Robella M., Vaira M., Marsanic P. et al. Treatment of pseudomyxoma peritonei with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): a single center experience. Minerva Chir. 2013; 68 (6): 569-77.

[7]	Беляев А.М., Багненко С.Ф., Рухляда Н.В. Внутрибрюшинная химиотерапия злокачественных опухолей брюшной полости. Монография. СПб.: ЭЛБИ-СПб; 2007.